Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Hellemons

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Haemostasis|May 18, 2001
Effect of oral anticoagulant treatment on markers for calcium and bone metabolismM H Knapen, B S Hellemons-Boode, M Langenberg-Ledeboer, et al.
BMJ (Clinical Research Ed.)|October 8, 1999
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirinB S Hellemons, M Langenberg, J Lodder, et al.
Controlled Clinical Trials|August 10, 1999
Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation: the PATAF trial study designB S Hellemons, M Langenberg, J Lodder, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Haemostasis|May 18, 2001
Effect of oral anticoagulant treatment on markers for calcium and bone metabolismM H Knapen, B S Hellemons-Boode, M Langenberg-Ledeboer, et al.
BMJ (Clinical Research Ed.)|October 8, 1999
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirinB S Hellemons, M Langenberg, J Lodder, et al.
Controlled Clinical Trials|August 10, 1999
Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation: the PATAF trial study designB S Hellemons, M Langenberg, J Lodder, et al.
Pageof 1